Global Ophthalmic Drugs and Devices Market 2023-2029

March 2023 | 62 pages | ID: G1A129BF9F94EN
Gen Consulting Company

Abstracts

According to the latest data, the market size of the global ophthalmic drugs and devices sector is expected to rise by USD 70.5 billion with a CAGR of 9.31% by the end of 2029. Ophthalmic drugs and devices are products used to treat various eye conditions and diseases. Ophthalmic drugs are medications that are administered directly to the eye or surrounding tissues to treat conditions such as glaucoma, dry eye, and macular degeneration. These drugs can be in the form of eye drops, ointments, gels, or injections. Ophthalmic devices, on the other hand, are medical devices that are designed to diagnose, treat, or prevent eye conditions. These devices can range from simple tools such as eye charts and magnifying glasses to complex instruments such as lasers and surgical tools used in cataract surgery.Ophthalmic drugs and devices are products used to treat various eye conditions and diseases. Ophthalmic drugs are medications that are administered directly to the eye or surrounding tissues to treat conditions such as glaucoma, dry eye, and macular degeneration. These drugs can be in the form of eye drops, ointments, gels, or injections. Ophthalmic devices, on the other hand, are medical devices that are designed to diagnose, treat, or prevent eye conditions. These devices can range from simple tools such as eye charts and magnifying glasses to complex instruments such as lasers and surgical tools used in cataract surgery.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global ophthalmic drugs and devices market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, treatment, and region. The global market for ophthalmic drugs and devices can be segmented by product: drugs, devices. Globally, the devices segment made up the largest share of the ophthalmic drugs and devices market. Ophthalmic drugs and devices market is further segmented by treatment: eye infections, allergic conjunctivitis, dry eyes syndrome, red eyes, inflammation, others. The eye infections segment captured the largest share of the market in 2022. Based on region, the ophthalmic drugs and devices market is segmented into: North America, Europe, Asia-Pacific, Rest of the World (RoW). According to the research, North America had the largest share in the global ophthalmic drugs and devices market.

The drugs market is further segmented into pilocarpine, MicroPine, Provisc, diuretics, vasoconstrictors, fluocinolone, Bimatoprost, others. The Provisc segment was the largest contributor to the global ophthalmic drugs and devices market in 2022. Furthermore, the devices market has been categorized into glasses and contact lens, optical dispenser, eye massagers, sponge devices and eye cleaner, others. The glasses and contact lens segment is estimated to account for the largest share of the global ophthalmic drugs and devices market.

Market Segmentation
By product: drugs, devices
By treatment: eye infections, allergic conjunctivitis, dry eyes syndrome, red eyes, inflammation, others
By region: North America, Europe, Asia-Pacific, Rest of the World (RoW)

The global ophthalmic drugs and devices market report offers detailed information on several market vendors, including Allergan plc, Johnson and Johnson, Alcon, Inc., Teva Pharmaceutical Industries Ltd., Ocular Therapeutix, Inc., Allergan plc, Bausch & Lomb Incorporated, Sight Sciences, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global ophthalmic drugs and devices market.
To classify and forecast the global ophthalmic drugs and devices market based on product, treatment, region.
To identify drivers and challenges for the global ophthalmic drugs and devices market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global ophthalmic drugs and devices market.
To identify and analyze the profile of leading players operating in the global ophthalmic drugs and devices market.

Why Choose This Report
Gain a reliable outlook of the global ophthalmic drugs and devices market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PRODUCT

Drugs
Devices

PART 6. MARKET BREAKDOWN BY TREATMENT

Eye infections
Allergic conjunctivitis
Dry eyes syndrome
Red eyes
Inflammation
Others

PART 7. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
Rest of the World (RoW)

PART 8. KEY COMPANIES

Allergan plc
Johnson and Johnson
Alcon, Inc.
Teva Pharmaceutical Industries Ltd.
Ocular Therapeutix, Inc.
Allergan plc
Bausch & Lomb Incorporated
Sight Sciences, Inc.

DISCLAIMER